Mammary tumor suppression by transforming growth factor beta 1 transgene expression - PubMed (original) (raw)

Mammary tumor suppression by transforming growth factor beta 1 transgene expression

D F Pierce Jr et al. Proc Natl Acad Sci U S A. 1995.

Abstract

In cell culture, type alpha transforming growth factor (TGF-alpha) stimulates epithelial cell growth, whereas TGF-beta 1 overrides this stimulatory effect and is growth inhibitory. Transgenic mice that overexpress TGF-alpha under control of the mouse mammary tumor virus (MMTV) promoter/enhancer exhibit mammary ductal hyperplasia and stochastic development of mammary carcinomas, a process that can be accelerated by administration of the chemical carcinogen 7,12-dimethylbenz[a]anthracene. MMTV-TGF-beta 1 transgenic mice display mammary ductal hypoplasia and do not develop mammary tumors. We report that in crossbreeding experiments involving the production of mice carrying both the MMTV-TGF-beta 1 and MMTV-TGF-alpha transgenes, there is marked suppression of mammary tumor formation and that MMTV-TGF-beta 1 transgenic mice are resistant to 7,12-dimethylbenz[a]anthracene-induced mammary tumor formation. These data demonstrate that overexpression of TGF-beta 1 in vivo can markedly suppress mammary tumor development.

PubMed Disclaimer

References

    1. Mol Cell Biol. 1990 Sep;10(9):4961-6 - PubMed
    1. Proc Natl Acad Sci U S A. 1986 Apr;83(8):2438-42 - PubMed
    1. Proc Natl Acad Sci U S A. 1991 Jan 1;88(1):276-80 - PubMed
    1. Mol Endocrinol. 1990 Jul;4(7):981-9 - PubMed
    1. Science. 1991 Nov 22;254(5035):1161-7 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources